Literature DB >> 1837591

Cis-active determinants of cardiac-specific expression in the human atrial natriuretic peptide gene.

J P Wu1, B Kovacic-Milivojević, M C Lapointe, K Nakamura, D G Gardner.   

Abstract

Expression of the human atrial natriuretic peptide (hANP)gene is controlled by a series of positive and negative cis-acting regulatory elements present in the 5' flanking sequences (5'FS) of the gene. Positive elements located between -1150 and -222, relative to the transcription start site, appear to be responsible for the major portion of ANP gene expression in neonatal rat cardiac atrial cells. While neonatal ventricular cardiocytes, at a qualitative level, seem to employ regulatory signals similar to their atrial counterparts, they do so with reduced efficiency. Expression of the hANP gene in nonmyocardial cells is limited by the presence of silencer elements in the distal (-2593 to -1150) and proximal (-222 to the CAP site) 5'FS. Further characterization of a 64-base pair cardiac-specific element (-410 to -332), described previously, revealed that a core sequence of 40 base pairs is required for functional activity. This core sequence includes a previously defined DNAse-I footprint region flanked by two GC-rich segments arranged in an inverted repeat-like array. These findings suggest that the disparity in atrial vs. ventricular cardiocyte expression of the ANP gene reflects differences that are largely quantitative in nature, while differences in myocardial vs. nonmyocardial cells result from fundamental qualitative differences in the way these cells recognize and use the regulatory elements present within the 5'FS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1837591     DOI: 10.1210/mend-5-9-1311

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

1.  Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1.

Authors:  Yang-Sook Chun; Ju-Yeon Hyun; Yong-Geun Kwak; In-San Kim; Chan-Hyung Kim; Eunjoo Choi; Myung-Suk Kim; Jong-Wan Park
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  Characterization of the 5'-flanking region and chromosomal assignment of the human brain natriuretic peptide gene.

Authors:  Y Ogawa; H Itoh; O Nakagawa; G Shirakami; N Tamura; T Yoshimasa; K Nagata; N Yoshida; K Nakao
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

3.  Divergent regulation of the human atrial natriuretic peptide gene by c-jun and c-fos.

Authors:  B Kovacic-Milivojević; D G Gardner
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

4.  Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle.

Authors:  S L Amacher; J N Buskin; S D Hauschka
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

5.  1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes.

Authors:  J Wu; M Garami; T Cheng; D G Gardner
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

6.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.

Authors:  O Nakagawa; Y Ogawa; H Itoh; S Suga; Y Komatsu; I Kishimoto; K Nishino; T Yoshimasa; K Nakao
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 7.  Structure and function of the Nppa-Nppb cluster locus during heart development and disease.

Authors:  Joyce Man; Phil Barnett; Vincent M Christoffels
Journal:  Cell Mol Life Sci       Date:  2018-01-04       Impact factor: 9.261

8.  Prediction of single-cell mechanisms for disease progression in hypertrophic remodelling by a trans-omics approach.

Authors:  Momoko Hamano; Seitaro Nomura; Midori Iida; Issei Komuro; Yoshihiro Yamanishi
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.